Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

19

Revenue 2014

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

McCann Health cleans up at the Lions Health Awards

McCann Health cleans up at the Lions Health Awards

In addition, 13 bronze trophies were handed out to groups including Boehringer Ingelheim’s Split Second, Roche’s Aviation and Merck’s Push campaign.

FDA panel backs CV claims for Novo Nordisk's Victoza

FDA panel backs CV claims for Novo Nordisk's Victoza Victoza is the second drug to get a recommendation for improving cardiovascular outcomes in type 2 diabetics after Eli Lilly and Boehringer Ingelheim's SGLT-2 inhibitor Jardiance (empagliflozin), which had

TFS appoints director of Marketing and Communications

TFS appoints director of Marketing and Communications He has also previously worked for Boehringer Ingelheim as a senior product manager and business information executive, and GlaxoSmithKline as a medical representative.

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching Latterly sales of Lantus have been hit by competition from other basal insulins as well as biosimilar versions of insulin glargine, including Eli Lilly and Boehringer's Basaglar which reached the

Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentials

Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentials The finding backs up the landmark EMPA-REG trial of Eli Lilly and Boehringer Ingelheim's Jardiance (empagliflozin), which was reported in 2015 and provides the first hard evidence of an ... Lilly and Boehringer have also said that EMPA-REG suggests

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Helen Lawn and Associates

Established in 2000, Helen Lawn and Associates has gained widespread industry recognition as a trusted, UK-based healthcare PR agency....

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics